“Severe Immune-Related Cutaneous Vasculitis Induced by Osimertinib”, acmcr, vol. 6, no. 4, pp. 524–527, Jul. 2022, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22639